Foot and Mouth Disease Vaccines Market (Type: Conventional Vaccines and Emergency Vaccines; Application: Cattle, Sheep & Goat, Pigs, and Others; and End User: Veterinary Clinics, Animal Farms, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Companies Broaden Production Capabilities to Manufacture Animal Coronavirus Vaccines

Companies in the foot and mouth disease vaccines market are capitalizing on value-grab opportunities to develop COVID-19 (coronavirus) vaccines that hold promising potentials to protect animals. For instance, Sinovac Biotech— a Beijing-based biopharmaceutical company is conducting clinical trials on rhesus macaques monkeys to innovate in its COVID-19 vaccine. In this way, manufacturers in the foot and mouth disease vaccines market are broadening their revenue streams by increasing their R&D activities in COVID-19 vaccines.

The demand for animal coronavirus vaccines is surging worldwide. Low to no side effects in animal coronavirus vaccines is highly preferred by companies in the livestock industry. Manufacturers are innovating in existing technologies to develop formulations consisting of a chemically inactivated version of the virus. Companies in lower middle-income countries are adopting these existing technologies to manufacture animal coronavirus vaccines. However, there is still a need to conduct clinical trials on several animals in order to validate the efficacy of animal coronavirus vaccines.

Multi-million Dollar Innovation Programs Fuel Demand for Foot and Mouth Disease Vaccines

Apart from business potentials in Asia and America, manufacturers in the foot and mouth disease vaccines market are exploring untapped opportunities in Eastern Africa. The Global Alliance for Livestock Veterinary Medicines (GALVmed) has announced the AgResults Foot and Mouth Disease (FMD) Vaccine Challenge Project to encourage the uptake of vaccines in Eastern Africa. Companies in the Africa foot and mouth disease vaccines market are improving their production capabilities to design vaccines that are tailored to the needs of livestock owners in Eastern Africa.

Multi-million dollar government initiatives are catalyzing the development of improved foot and mouth disease vaccines. Since FMD is highly contagious and has devastating effects on the livestock industry, manufacturers are increasing the availability of foot and mouth disease vaccines.

Increasing Production Targets Help Meet Growing FMD Demands

Asia Pacific is among the second-highest revenue earning regions in the foot and mouth disease vaccines market, which is expected to grow at a rapid pace during the forecast period. India being one of the major countries in Asia Pacific is gearing up to tackle the issue of high prevalence of foot and mouth diseases among livestock. Announced by India’s Prime Minister Narendra Modi himself, the National Animal Disease Control Program (NADCP) is under spotlight for ensuring the welfare of buffalo and cattle population.

Fund allocations by government organizations are generating incremental opportunities for pharmaceutical companies in the India foot and mouth disease vaccines market. However, it is challenging to have sufficient quantities of foot and mouth disease vaccines in order to fast-track vaccination programs. As such, veterinary scientists opine that vaccine companies in India are increasing their production targets to meet FMD demands.

Incremental Opportunities in Mongolia Drive R&D Innovations in Immunogenicity Studies

As companies gear up to tap into incremental opportunities in the Asia Pacific foot and mouth disease vaccines market, Mongolia is another country, which is witnessing the demand for vaccines. FMD is a high impact viral disease of livestock and is found to have regular incursions in eastern regions of Mongolia. Such demands are estimated to bolster revenue growth for the overall Asia Pacific foot and mouth disease vaccines market. As such, the country imports vaccines and this forms an important part of their disease control strategy.

Pharmaceutical companies are abiding by the post-vaccination monitoring guidelines published by the FAO (Food and Agriculture Organization of the United Nations)-OIE (World Organisation for Animal Health) that provide information on the appropriateness of imported foot and mouth disease vaccines. Manufacturers are increasing their R&D capabilities in immunogenicity studies to produce improved formulations of vaccines.

Synthetic Foot and Mouth Disease Vaccines Trigger Optimum Immune Responses in Animals

The global foot and mouth disease vaccines market is expected to reach US$ 11.2 Bn by the end of 2030, as companies such as MSD Animal Health— a provider of innovative veterinary pharmaceuticals and vaccines, has collaborated with scientists at the University of Oxford, Diamond Light Source, Pirbright, and the University of Reading to gain commercial license for FMD vaccines. Companies in the foot and mouth disease vaccines market are increasing the availability of effective and affordable vaccines that are designed to combat several strains of foot and mouth disease virus (FMDV).

Manufacturers are increasing their efficacy in the development of synthetic vaccines capable of triggering optimum immune responses sans the need to grow live infectious viruses. These synthetic foot and mouth disease vaccines are reducing the risks of potential infections and contamination in livestock.

Synthetic Biology Eliminates Use of Live FMDV in Vaccine Production

The foot and mouth disease vaccines market is anticipated to mature at a CAGR of ~7% during the forecast period. This is evident, as new patent-pending processes are in pipeline that are a breakthrough in foot and mouth disease vaccine innovations. For instance, inventors at the Plum Island Animal Disease Center (PIADC) have published a patent application titled “Modified Picornavirus 3C Proteases and Methods Thereof” and is being recognized by the World Intellectual Property Organization (WIPO).

North America dictates the highest revenue among all regions in the foot and mouth disease vaccines market. However, manufacturing of foot and mouth disease vaccines is strictly prohibited in the U.S., since risks of accidental outbreaks during the manufacturing procedure are possible. Hence, companies are adopting the techniques of synthetic biology that eliminates the need to use live FMDV for vaccine production.

Analysts’ Viewpoint

Companies are capitalizing on revenue opportunities in animal coronavirus vaccines that are capable of producing positive outcomes in rhesus macaques monkeys. Governments in Australia are adopting the flexible policy model that allows decision makers to determine the role of FMD vaccines in specific outbreak scenarios. However, there is a need for more safe production practices in the U.S. so that the country maintains its position of an FMD-free nation. Hence, companies in the foot and mouth disease vaccines market should adopt synthetic biology to eliminate the need of live FMD virus for vaccine production, which helps to prevent potential outbreaks, since FMD is highly contagious.

Foot and Mouth Disease Vaccines Market: Overview

According to Transparency Market Research’s latest research report on the global foot and mouth disease vaccines market for the historical period (2018–2019) and the forecast period (2020–2030), increase in awareness about veterinary care is projected to drive the global foot and mouth disease vaccines market in the near future

According to the report, the global foot and mouth disease vaccines market was valued at US$ 5.5 Bn in 2019 and is anticipated to expand at a CAGR of ~7% from 2020 to 2030

Increase in Awareness about Veterinary Care: Key Driver

Awareness about animal diseases, their symptoms, and medication are important for livestock owners. Several animal health awareness programs have been conducted to spread awareness among people. For instance, the Agriculture and Animal Health Awareness Programme was organized at Panchot GP-Gujarat, India, to raise awareness among people about animal healthcare and generate employment.

Rise in awareness about veterinary care enhances the level of control and care of animals. This, in turn, increases the number of animals. Moreover, changes in veterinary education in the last few decades placed more emphasis on animal welfare owing to greater awareness about animal healthcare.

Government and private sector organizations are engaged in spreading awareness about the importance of animal care. For instance, the American Animal Hospital Association is a non-profit organization for companion animal veterinary hospitals. It is an accrediting body for small animal hospitals in the U.S. and Canada.

The One Health initiative has also increased awareness among the people. One Health is an integrative effort of multiple disciplines working locally, nationally, and globally to attain optimal health for people, animals, and the environment, and increase awareness, knowledge, and understanding between people. Rise in awareness about new healthcare techniques & disease indications and high protectiveness of owners about their pet and livestock health are the factors expected to drive the global market.

In August 2019, the HELP University launched Ninth AniHELP event. The primary aim was to create awareness about the importance of animal adoption and prevention of cruelty to animals.

Hence, rise in awareness about veterinary care is likely to augment the global market

Surge in Incidence of Zoonotic Diseases: Major Driver

Globalization and climate change lead to outbreak of animal diseases; some of these are transmissible to humans. According to IFAH Europe (2015), rise in global temperatures leads to appearance of new diseases and helps other diseases to reappear.

Most human infections with zoonoses come from livestock. Zoonotic diseases account for 61% of the total animal diseases. For instance, porcine parvovirus and foot and mouth disease are the major diseases in animals.

Vaccines used for porcine parvovirus are Lambivac, M+PAC, and Porcilis Ery. Foot and mouth disease vaccines account for the largest share of the veterinary vaccines market, which accounted for 26.4% of the global livestock industry.

Social and cultural factors such as food habits and religious beliefs also play a vital role in spreading of disease to humans. Examples are avian influenza, bovine spongiform encephalitis (BSE), and the Nipah virus. A number of factors lead to the emergence of zoonotic diseases.

The geographical range of zoonotic pathogens such as West Nile virus (WNV), chikungunya virus (CHIKV), and dengue virus are expanding, with the movement of vectors into newly established habitats

Foot and Mouth Disease Vaccines Market: Competition Landscape

This report profiles major players operating in the global foot and mouth disease vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global foot and mouth disease vaccines market is moderately fragmented, with the presence of a large number of leading players in the international market and several small players in regional markets. The top players hold major share of the global foot and mouth disease vaccines market.

Prominent players operating in the global foot and mouth disease vaccines market include 

• India Immunological Ltd.
• Merck Animal Health
• Brilliant Bio Pharma Ltd.
• Ceva Santé Animale
• Boehringer Ingelheim GmbH
• Biovet Private Limited
• Biovencer Healthcare Private Limited
• Vetal Animal Health Products S.A
• Biogenesis Bago SA

The report on the global foot and mouth disease vaccines market discusses individual strategies, followed by company profiles of manufacturers of vaccines. The ‘competition landscape’ section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global foot and mouth disease vaccines market.

Key Questions Answered in Foot and Mouth Disease Vaccines Market Report

• What is the scope of growth of devices and its companies in the global foot and mouth disease vaccines market and its application segment?
• What will be the Y-o-Y growth of the global foot and mouth disease vaccines market between 2020 and 2030?
• What is the influence of changing trends in technologies on the global foot and mouth disease vaccines market?
• Will North America continue to be the most profitable regional market for foot and mouth disease vaccine providers?
• Which factors will impede the growth of the global foot and mouth disease vaccines market during the forecast period?
• Which are the leading companies in the global foot and mouth disease vaccines market?

Foot and Mouth Disease Vaccines Market – Segmentation

Type

• Conventional Vaccines
• Aluminum Hydroxide/Saponin-based Vaccines
• Oil-based Vaccines
• Emergency Vaccines

Application

• Cattle
• Sheep & Goat
• Pigs
• Others (Antelope, Deer, Bison, and Camelids)

End User

• Veterinary Clinics
• Animal Farms
• Others

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Foot and Mouth Disease Vaccines Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Foot and Mouth Disease Vaccines Market Analysis and Forecast, 2018–2030

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Regulatory Scenario by Region/Globally

    5.2. Key Mergers & Acquisitions 

6. Global Foot and Mouth Disease Vaccines Market Analysis and Forecast, by Type 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Foot and Mouth Disease Vaccines Market Value Forecast, by Type, 2018–2030

        6.3.1. Conventional Vaccines 

            6.3.1.1. Aluminum Hydroxide/Saponin-based Vaccines

            6.3.1.2. Oil-based Vaccines

        6.3.2. Emergency Vaccines 

    6.4. Global Foot and Mouth Disease Vaccines Market Attractiveness Analysis, by Type 

7. Global Foot and Mouth Disease Vaccines Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Foot and Mouth Disease Vaccines Market Value Forecast, by Application, 2018–2030

        7.3.1. Cattle

        7.3.2. Sheep & Goat

        7.3.3. Pigs

        7.3.4. Others (antelope, deer, bison, and camelids)

    7.4. Global Foot and Mouth Disease Vaccines Market Attractiveness Analysis, by Application

8. Global Foot and Mouth Disease Vaccines Market Analysis and Forecast, by End-user 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Foot and Mouth Disease Vaccines Market Value Forecast, by End-user, 2018–2030

        8.3.1. Veterinary Clinics

        8.3.2. Animal Farms

        8.3.3. Others

    8.4. Global Foot and Mouth Disease Vaccines Market Attractiveness Analysis, by End-user 

9. Global Foot and Mouth Disease Vaccines Market Analysis and Forecast, by Region

    9.1. 10.1. Key Findings

    9.2. 10.2. Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Global Foot and Mouth Disease Vaccines Market Attractiveness Analysis, by Region

10. North America Foot and Mouth Disease Vaccines Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Foot and Mouth Disease Vaccines Market Value Forecast, by Type, 2018–2030

        10.2.1. Conventional Vaccines 

            10.2.1.1. Aluminum Hydroxide/Saponin-based Vaccines

            10.2.1.2. Oil-based Vaccines

        10.2.2. Emergency Vaccines 

    10.3. North America Foot and Mouth Disease Vaccines Market Value Forecast, by Application, 2018–2030

        10.3.1. Cattle

        10.3.2. Sheep & Goat

        10.3.3. Pigs

        10.3.4. Others (antelope, deer, bison, and camelids)

    10.4. North America Foot and Mouth Disease Vaccines Market Value Forecast, by End-user, 2018–2030

        10.4.1. Veterinary Clinics

        10.4.2. Animal Farms

        10.4.3. Others

    10.5. North America Foot and Mouth Disease Vaccines Market Value Forecast, by Country, 2018–2030

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Foot and Mouth Disease Vaccines Market Attractiveness Analysis 

        10.6.1. By Type 

        10.6.2. By Application 

        10.6.3. By End-user 

        10.6.4. By Country

11. Europe Foot and Mouth Disease Vaccines Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Foot and Mouth Disease Vaccines Market Value Forecast, by Type, 2018–2030

        11.2.1. Conventional Vaccines 

            11.2.1.1. Aluminum Hydroxide/Saponin-based Vaccines

            11.2.1.2. Oil-based Vaccines

        11.2.2. Emergency Vaccines 

    11.3. Europe Foot and Mouth Disease Vaccines Market Value Forecast, by Application, 2018–2030

        11.3.1. Cattle

        11.3.2. Sheep & Goat

        11.3.3. Pigs

        11.3.4. Others (antelope, deer, bison, and camelids)

    11.4. Europe Foot and Mouth Disease Vaccines Market Value Forecast, by End-user, 2018–2030

        11.4.1. Veterinary Clinics

        11.4.2. Animal Farms

        11.4.3. Others

    11.5. Europe Foot and Mouth Disease Vaccines Market Value Forecast, by Country/Sub-region, 2018–2030

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Foot and Mouth Disease Vaccines Market Attractiveness Analysis 

        11.6.1. By Type 

        11.6.2. By Application

        11.6.3. By End-user 

        11.6.4. By Country/Sub-region

12. Asia Pacific Foot and Mouth Disease Vaccines Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Foot and Mouth Disease Vaccines Market Value Forecast, by Type, 2018–2030

        12.2.1. Conventional Vaccines 

            12.2.1.1. Aluminum Hydroxide/Saponin-based Vaccines

            12.2.1.2. Oil-based Vaccines

        12.2.2. Emergency Vaccines 

    12.3. Asia Pacific Foot and Mouth Disease Vaccines Market Value Forecast, by Application, 2018–2030

        12.3.1. Cattle

        12.3.2. Sheep & Goat

        12.3.3. Pigs

        12.3.4. Others (antelope, deer, bison, and camelids)

    12.4. Asia Pacific Foot and Mouth Disease Vaccines Market Value Forecast, by End-user, 2018–2030

        12.4.1. Veterinary Clinics

        12.4.2. Animal Farms

        12.4.3. Others

    12.5. Asia Pacific Foot and Mouth Disease Vaccines Market Value Forecast, by Country/Sub-region, 2018–2030

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Foot and Mouth Disease Vaccines Market Attractiveness Analysis 

        12.6.1. By Type 

        12.6.2. By Application

        12.6.3. By End-user 

        12.6.4. By Country/Sub-region

13. Latin America Foot and Mouth Disease Vaccines Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Foot and Mouth Disease Vaccines Market Value Forecast, by Type, 2018–2030

        13.2.1. Conventional Vaccines 

            13.2.1.1. Aluminum Hydroxide/Saponin-based Vaccines

            13.2.1.2. Oil-based Vaccines

        13.2.2. Emergency Vaccines 

    13.3. Latin America Foot and Mouth Disease Vaccines Market Value Forecast, by Application, 2018–2030

        13.3.1. Cattle

        13.3.2. Sheep & Goat

        13.3.3. Pigs

        13.3.4. Others (antelope, deer, bison, and camelids)

    13.4. Latin America Foot and Mouth Disease Vaccines Market Value Forecast, by End-user, 2018–2030

        13.4.1. Veterinary Clinics

        13.4.2. Animal Farms

        13.4.3. Others

    13.5. Latin America Foot and Mouth Disease Vaccines Market Value Forecast, by Country/Sub-region, 2018–2030

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Foot and Mouth Disease Vaccines Market Attractiveness Analysis 

        13.6.1. By Type 

        13.6.2. By Application

        13.6.3. By End-user 

        13.6.4. By Country/Sub-region

14. Middle East & Africa Foot and Mouth Disease Vaccines Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Foot and Mouth Disease Vaccines Market Value Forecast, by Type, 2018–2030

        14.2.1. Conventional Vaccines 

            14.2.1.1. Aluminum Hydroxide/Saponin-based Vaccines

            14.2.1.2. Oil-based Vaccines

        14.2.2. Emergency Vaccines 

    14.3. Middle East & Africa Foot and Mouth Disease Vaccines Market Value Forecast, by Application, 2018–2030

        14.3.1. Cattle

        14.3.2. Sheep & Goat

        14.3.3. Pigs

        14.3.4. Others (antelope, deer, bison, and camelids)

    14.4. Middle East & Africa Foot and Mouth Disease Vaccines Market Value Forecast, by End-user, 2018–2030

        14.4.1. Veterinary Clinics

        14.4.2. Animal Farms

        14.4.3. Others

    14.5. Middle East & Africa Foot and Mouth Disease Vaccines Market Value Forecast, by Country/Sub-region, 2018–2030

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Foot and Mouth Disease Vaccines Market Attractiveness Analysis 

        14.6.1. By Type 

        14.6.2. By Application

        14.6.3. By End-user 

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2019

    15.3. Company Profiles

        15.3.1. India Immunological Ltd.

            15.3.1.1. Company Overview

            15.3.1.2. Company Financials

            15.3.1.3. Growth Strategies

            15.3.1.4. SWOT Analysis

        15.3.2. Merck Animal Health

            15.3.2.1. Company Overview

            15.3.2.2. Company Financials

            15.3.2.3. Growth Strategies

            15.3.2.4. SWOT Analysis

        15.3.3. Brilliant Bio Pharma Ltd.

            15.3.3.1. Company Overview

            15.3.3.2. Company Financials

            15.3.3.3. Growth Strategies

            15.3.3.4. SWOT Analysis

        15.3.4. Ceva

            15.3.4.1. Company Overview

            15.3.4.2. Company Financials

            15.3.4.3. Growth Strategies

            15.3.4.4. SWOT Analysis

        15.3.5. Boehringer Ingelheim GmbH (1/3)

            15.3.5.1. Company Overview

            15.3.5.2. Company Financials

            15.3.5.3. Growth Strategies

            15.3.5.4. SWOT Analysis

        15.3.6. Biovet Private Limited

            15.3.6.1. Company Overview

            15.3.6.2. Company Financials

            15.3.6.3. Growth Strategies

            15.3.6.4. SWOT Analysis

        15.3.7. Biovencer Healthcare Private Limited

            15.3.7.1. Company Overview

            15.3.7.2. Company Financials

            15.3.7.3. Growth Strategies

            15.3.7.4. SWOT Analysis

        15.3.8. Vetal Animal Health Products S.A.

            15.3.8.1. Company Overview

            15.3.8.2. Company Financials

            15.3.8.3. Growth Strategies

            15.3.8.4. SWOT Analysis

        15.3.9. Biogenesis Bago SA

            15.3.9.1. Company Overview

            15.3.9.2. Company Financials

            15.3.9.3. Growth Strategies

            15.3.9.4. SWOT Analysis